PATENT CLAIM ANALYSIS

Application Number: 15509466
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "049000"]

Abstract:
The present invention relates to cysteamine, cystamine, or derivatives thereof, for use in the treatment and/or prevention of infection caused by the bacterium,  Mycobacterium  spp., in particular  Mycobacterium abscessus , or a disease or condition associated therewith.

Claim (Index 4):
The amino thiol compound of  claim 1  wherein the infection is a biofilm infection.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 90.0
- Lexical Diversity: 1.30303
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14460953', '15669289', '14675218', '13945257', '13349789']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.725173843327613
- 35 USC 102 Novelty (BERT): 0.5082950761567508
- Combined Prediction Score: 0.7034859666105268
- Mean Citation Score: 192.27938
- Max Citation Score: 197.42651
- Similarity Product: 111.18997438250425

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test